Purpose of the development: For the diagnosis of cancer, to determine the individual violations and of the "targeted" (targeted) therapy.

Recommended application field: Hospitals, medical and biological laboratories, clinics.

Advantages over analogues: Differential diagnosis of a variety of severe pathologies such as malignancies. Early diagnosis of tumors of different origin. Forecasting the course of cancer. Definition of objects of targeted therapies and improved therapeutic interventions.

The development stage readiness: tested in laboratory condition

Description of the development:
()
Create custom profiles of gene disorders, there is a prerequisite for the application of the so-called "targeted" (targeted) therapy. The main purpose of this therapy is to direct treatment, aimed at identifying and impact on specific pathological change without inhibition of normal bodily functions. To determine the objects of targeted therapy and determination of individual violations of used technology of total screening of the genome, such as through the use of microarray technology. For the full genome screening damages the human genome in the world used the system design and application of microarray-based oligonucleotide probes.

corresponds technical description
Guarantees stable results getting

Possibility of transfer abroad:
Combinated reduction to industrial level

Photo

Country Ukraine

For additional information turn to:
E-mail: gal@uintei.kiev.ua